PVP Ventures Acquires 52% Stake in Medilabs to Expand Healthcare Reach
ECONOMY & POLICY

PVP Ventures Acquires 52% Stake in Medilabs to Expand Healthcare Reach

PVP Ventures Limited (PVP) has announced the acquisition of a 52% stake in Biohygea Global Private Limited, known under the brand name Medilabs, marking a significant milestone in its ambition to build a comprehensive global healthcare services platform. This move aligns with PVP’s previously outlined strategy focusing on illness, wellness, and care, with a special emphasis on underserved markets.

The acquisition includes both primary and secondary stake purchases, securing PVP an initial 52% shareholding. PVP also plans to increase its stake over time through additional tranches. Established in 2014 by Dr Prakash, a radiologist, and G Dillibabu, a hospital and lab operations expert, Medilabs operates diagnostic centres and collaborates with local hospitals to set up labs within their premises. It offers a wide test menu of over 1,500 tests and includes facilities such as CT imaging and ultrasound services.

With this partnership, Medilabs will now focus on strengthening its position in Tier 2 and Tier 3 cities, positioning itself as a differentiated diagnostics player in the areas of fetal medicine, genomics, and oncology testing.

Arjun Ananth, CEO of PVP Ventures, commented, “This transaction fills a critical service offering in our strategy of building a powerful house of brands in healthcare services focused on Tier 2 and Tier 3 markets. We welcome Medilab into the PVP fold and look forward to making them a differentiated and scaled diagnostics player in the near future.”

PVP Ventures Limited (PVP) has announced the acquisition of a 52% stake in Biohygea Global Private Limited, known under the brand name Medilabs, marking a significant milestone in its ambition to build a comprehensive global healthcare services platform. This move aligns with PVP’s previously outlined strategy focusing on illness, wellness, and care, with a special emphasis on underserved markets. The acquisition includes both primary and secondary stake purchases, securing PVP an initial 52% shareholding. PVP also plans to increase its stake over time through additional tranches. Established in 2014 by Dr Prakash, a radiologist, and G Dillibabu, a hospital and lab operations expert, Medilabs operates diagnostic centres and collaborates with local hospitals to set up labs within their premises. It offers a wide test menu of over 1,500 tests and includes facilities such as CT imaging and ultrasound services. With this partnership, Medilabs will now focus on strengthening its position in Tier 2 and Tier 3 cities, positioning itself as a differentiated diagnostics player in the areas of fetal medicine, genomics, and oncology testing. Arjun Ananth, CEO of PVP Ventures, commented, “This transaction fills a critical service offering in our strategy of building a powerful house of brands in healthcare services focused on Tier 2 and Tier 3 markets. We welcome Medilab into the PVP fold and look forward to making them a differentiated and scaled diagnostics player in the near future.”

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code